Economic Impact of Reducing Hospital Admissions for Patients Presenting to the Emergency Department With Worsening Heart Failure: An Adaptive Clinical Trial of Furoscix Infusor
Status: Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 13 Nov 2019
Price : $35 *
At a glance
- Drugs Furosemide (Primary) ; Furosemide
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms FREEDOM-HF
- Sponsors scPharmaceuticals
- 07 Nov 2019 Planned End Date changed from 1 Jun 2020 to 1 Jul 2021.
- 07 Nov 2019 Planned primary completion date changed from 1 Mar 2020 to 1 May 2021.
- 07 Nov 2019 Planned initiation date changed from 1 Jun 2019 to 1 Aug 2020.